Is PAD a Hypercoagulable Disorder?
作者信息
Smilowitz Nathaniel R, Berger Jeffrey S
机构信息
Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York.
出版信息
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):387-389. doi: 10.1161/ATVBAHA.120.315209. Epub 2020 Dec 23.
Abstract
摘要
相似文献
1
Is PAD a Hypercoagulable Disorder?外周动脉疾病是一种高凝性疾病吗？
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):387-389. doi: 10.1161/ATVBAHA.120.315209. Epub 2020 Dec 23.
2
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.基于止血因子的孟德尔随机化分析及其对外周动脉疾病的影响——简短报告
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):380-386. doi: 10.1161/ATVBAHA.119.313847. Epub 2020 Aug 27.
3
von Willebrand factor and factor VIII in a healthy Brazilian population. Association with ABO blood groups.巴西健康人群中的血管性血友病因子和凝血因子VIII。与ABO血型的关联。
Thromb Res. 2020 Apr;188:49-51. doi: 10.1016/j.thromres.2020.02.002. Epub 2020 Feb 4.
4
Endothelial Dysfunction, Atherosclerosis, and Increase of Von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine.内皮功能障碍、动脉粥样硬化与血管性血友病因子及凝血因子 VIII 水平升高：一项猪的随机对照试验
Thromb Haemost. 2021 May;121(5):552. doi: 10.1055/a-1347-8761. Epub 2021 Feb 18.
5
Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.随着年龄的增长，血管性血友病因子和因子 VIII 水平的升高：遗传和获得性危险因素的作用。
Thromb Res. 2021 Jan;197:172-178. doi: 10.1016/j.thromres.2020.11.016. Epub 2020 Nov 16.
6
Efficacy of factor VIII/von Willebrand factor concentrate Alphanate in preventing excessive bleeding during surgery in subjects with von Willebrand disease.VIII因子/血管性血友病因子浓缩物Alphanate在预防血管性血友病患者手术期间过度出血方面的疗效。
Haemophilia. 2008 Mar;14(2):271-5. doi: 10.1111/j.1365-2516.2007.01616.x. Epub 2008 Jan 8.
7
Effect of desmopressin on plasma factor VIII and von Willebrand factor concentrations in Greyhounds.去氨加压素对灵缇犬血浆凝血因子VIII和血管性血友病因子浓度的影响。
Aust Vet J. 1998 Dec;76(12):809-12. doi: 10.1111/j.1751-0813.1998.tb12332.x.
8
Treatment of von Willebrand disease.血管性血友病的治疗。
Haemophilia. 1998 Jul;4(4):661-4. doi: 10.1046/j.1365-2516.1998.440661.x.
9
THE MECHANISM OF THE HEMOSTATIC FUNCTION OF BLOOD PLATELETS.血小板止血功能的机制。
Acta Haematol. 1964 Apr;31:230-8. doi: 10.1159/000209632.
10
Assay of antihaemophilic factor using the prothrombin conversion ratio.使用凝血酶原转化比率测定抗血友病因子
Br J Haematol. 1956 Oct;2(4):386-96. doi: 10.1111/j.1365-2141.1956.tb06713.x.
本文引用的文献
1
Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.基于止血因子的孟德尔随机化分析及其对外周动脉疾病的影响——简短报告
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):380-386. doi: 10.1161/ATVBAHA.119.313847. Epub 2020 Aug 27.
2
A Bon VOYAGER for Peripheral Artery Disease.外周动脉疾病的“一路顺风”。 （感觉这个英文表述不太常规，这样翻译可能不太能准确理解其确切含义，正常可能应该是针对外周动脉疾病的某种产品或项目叫“A Bon VOYAGER” ，直译为“一位前往外周动脉疾病的‘一路顺风者’” ，但这样表述很奇怪，你可以检查下原文是否准确 。 ）
N Engl J Med. 2020 May 21;382(21):2047-2048. doi: 10.1056/NEJMe2007274.
3
Rivaroxaban in Peripheral Artery Disease after Revascularization.利伐沙班治疗血管重建术后外周动脉疾病
N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28.
4
Genome-wide association study of peripheral artery disease in the Million Veteran Program.在百万退伍军人计划中进行的外周动脉疾病全基因组关联研究。
Nat Med. 2019 Aug;25(8):1274-1279. doi: 10.1038/s41591-019-0492-5. Epub 2019 Jul 8.
5
Circulating monocyte-platelet aggregates are a robust marker of platelet activity in cardiovascular disease.循环单核细胞-血小板聚集体是心血管疾病中血小板活性的一个强有力的标志物。
Atherosclerosis. 2019 Mar;282:11-18. doi: 10.1016/j.atherosclerosis.2018.12.029. Epub 2019 Jan 2.
6
Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.全基因组关联跨种族荟萃分析鉴定出调控凝血因子 VIII 和血管性血友病因子血浆水平的新关联。
Circulation. 2019 Jan 29;139(5):620-635. doi: 10.1161/CIRCULATIONAHA.118.034532.
7
Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia.外周动脉疾病患者的肢体严重缺血的病理学。
J Am Coll Cardiol. 2018 Oct 30;72(18):2152-2163. doi: 10.1016/j.jacc.2018.08.002. Epub 2018 Aug 27.
8
Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease.血小板衍生的 MRP-14 诱导有症状外周动脉疾病患者的单核细胞活化。
J Am Coll Cardiol. 2018 Jan 2;71(1):53-65. doi: 10.1016/j.jacc.2017.10.072.
9
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.利伐沙班联合或不联合阿司匹林治疗稳定的外周动脉或颈动脉疾病患者：一项国际、随机、双盲、安慰剂对照试验。
Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10.
10
Antithrombotic therapy in peripheral artery disease.外周动脉疾病的抗栓治疗
Lancet. 2018 Jan 20;391(10117):183-184. doi: 10.1016/S0140-6736(17)32847-7. Epub 2017 Nov 10.
Zotero 插件